Literature DB >> 32748257

Major complications in extreme lateral interbody fusion access: multicentric study by Italian S.O.L.A.S. group.

Andrea Piazzolla1, Davide Bizzoca1, Pedro Berjano2, Massimo Balsano3, Josip Buric4, Stefano Carlucci5, Carlo Formica6, Matteo Formica7, Claudio Lamartina6, Corrado Musso8, Francesco Tamburrelli9, Marco Damilano6, Fulvio Tartara10, Aldo Sinigaglia6, Roberto Bassani11, Massimiliano Neroni12, Giovanni Casero11, Alessio Lovi12, Diego Garbossa13, Zullo Nicola8, Biagio Moretti1.   

Abstract

PURPOSE: The eXtreme Lateral Interbody Fusion (XLIF) approach has gained increasing importance in the last decade. This multicentric retrospective cohort study aims to assess the incidence of major complications in XLIF procedures performed by experienced surgeons and any relationship between the years of experience in XLIF procedures and the surgeon's rate of severe complications.
METHODS: Nine Italian members of the Society of Lateral Access Surgery (SOLAS) have taken part in this study. Each surgeon has declared how many major complications have been observed during his surgical experience and how they were managed. A major complication was defined as an injury that required reoperation, or as a complication, whose sequelae caused functional limitations to the patient after one year postoperatively. Each surgeon was finally asked about his years of experience in spine surgery and XLIF approach. Pearson correlation test was used to evaluate the association between the surgeon's years of experience in XLIF and the rate of major complications; a p-value of last than 0.05 was considered significant.
RESULTS: We observed 14 major complications in 1813 XLIF procedures, performed in 1526 patients. The major complications rate was 0.7722%. Ten complications out of fourteen needed a second surgery. Neither cardiac nor respiratory nor renal complications were observed. No significant correlation was found between the surgeon's years of experience in the XLIF procedure and the number of major complications observed.
CONCLUSION: XLIF revealed a safe and reliable surgical procedure, with a very low rate of major complications, when performed by an expert spine surgeon.

Entities:  

Keywords:  Adult scoliosis; Complication; Degenerative disc disease; Low-back pain; Minimally invasive spine surgery; eXtreme lateral interbody fusion (XLIF)

Year:  2020        PMID: 32748257     DOI: 10.1007/s00586-020-06542-0

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  20 in total

1.  Extreme lateral approach to the spine in degenerative and post traumatic lumbar diseases: selection process, results and complications.

Authors:  Matteo Formica; Pedro Berjano; Luca Cavagnaro; Andrea Zanirato; Andrea Piazzolla; Carlo Formica
Journal:  Eur Spine J       Date:  2014-09-12       Impact factor: 3.134

2.  Minimally invasive lateral transpsoas approach with advanced neurophysiologic monitoring for lumbar interbody fusion.

Authors:  Pedro Berjano; Claudio Lamartina
Journal:  Eur Spine J       Date:  2011-09       Impact factor: 3.134

3.  Anterior column realignment (ACR) technique for correction of sagittal imbalance.

Authors:  Pedro Berjano; Marco Damilano; Maryem Ismael; Alessandro Longo; Antonio Bruno; Claudio Lamartina
Journal:  Eur Spine J       Date:  2015-04       Impact factor: 3.134

4.  Sagittal alignment correction and reconstruction of lumbar post-traumatic kyphosis via MIS lateral approach.

Authors:  Pedro Berjano; Marco Damilano; Claudio Lamartina
Journal:  Eur Spine J       Date:  2012-12       Impact factor: 3.134

Review 5.  Complications of the lateral transpsoas approach for lumbar interbody arthrodesis: a case series and literature review.

Authors:  D'Mitri A Sofianos; Michael R Briseño; Joshua Abrams; Alpesh A Patel
Journal:  Clin Orthop Relat Res       Date:  2012-06       Impact factor: 4.176

Review 6.  The role of minimally invasive lateral lumbar interbody fusion in sagittal balance correction and spinal deformity.

Authors:  Giuseppe Costanzo; Carmine Zoccali; Philip Maykowski; Christina M Walter; Jesse Skoch; Ali A Baaj
Journal:  Eur Spine J       Date:  2014-09-13       Impact factor: 3.134

7.  Fusion rate following extreme lateral lumbar interbody fusion.

Authors:  Pedro Berjano; Francesco Langella; Marco Damilano; Matteo Pejrona; Josip Buric; Maryem Ismael; Jorge Hugo Villafañe; Claudio Lamartina
Journal:  Eur Spine J       Date:  2015-04-17       Impact factor: 3.134

8.  Extreme Lateral Interbody Fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion.

Authors:  Burak M Ozgur; Henry E Aryan; Luiz Pimenta; William R Taylor
Journal:  Spine J       Date:  2006 Jul-Aug       Impact factor: 4.166

9.  Substantial clinical benefit of minimally invasive lateral interbody fusion for degenerative spondylolisthesis.

Authors:  Kaveh Khajavi; Alessandria Shen; Anthony Hutchison
Journal:  Eur Spine J       Date:  2015-03-24       Impact factor: 3.134

View more
  4 in total

1.  Complication rates following stand-alone lateral interbody fusion: a single institution series after 10 years of experience.

Authors:  Periklis Godolias; Zachary L Tataryn; Sven Frieler; Ravi Nunna; Kaarina Charlot; Angela Tran; Jonathan Plümer; Charlotte Cibura; Hamzah Al-Awadi; Zeyad Daher; Marcel Dudda; Thomas A Schildhauer; Jens Chapman; Rod Oskouian
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-10-14

2.  Postoperative spinal alignment comparison of lateral versus supine patient position L5-S1 anterior lumbar interbody fusion.

Authors:  Kaveh Khajavi; Cristiano M Menezes; Brett A Braly; J Alex Thomas
Journal:  Eur Spine J       Date:  2022-05-25       Impact factor: 2.721

3.  Rapidly destructive osteoarthritis of the spine: lessons learned from the first reported case.

Authors:  Alice Baroncini; Pedro Berjano; Filippo Migliorini; Claudio Lamartina; Daniele Vanni; Stefano Boriani
Journal:  BMC Musculoskelet Disord       Date:  2022-08-01       Impact factor: 2.562

4.  Extreme lateral interbody fusion (XLIF) in a consecutive series of 72 patients.

Authors:  Mirza Pojskic; Benjamin Saβ; Benjamin Völlger; Christopher Nimsky; Barbara Carl
Journal:  Bosn J Basic Med Sci       Date:  2021-10-01       Impact factor: 3.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.